Search

Your search keyword '"Chung, Junho"' showing total 516 results

Search Constraints

Start Over You searched for: Author "Chung, Junho" Remove constraint Author: "Chung, Junho"
516 results on '"Chung, Junho"'

Search Results

3. The BTLA–HVEM axis restricts CAR T cell efficacy in cancer

10. Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study

11. Heterologous vaccination utilizing viral vector and protein platforms confers complete protection against SFTSV

13. Spatial epitranscriptomics reveals A-to-I editome specific to cancer stem cell microniches

14. Follow-up on phase 1 study of AT101, a novel anti-CD19 chimeric antigen receptor cell therapy (CAR-T) in patients with relapsed or refractory (r/r) b-cell non-Hodgkin lymphoma.

26. Abstract CT130: An open label, dose escalation, phase 1 study of AT101, a novel CD19-directed CAR-T cell therapy targeting a membrane-proximal epitope of CD19, in patients with relapsed or refractory B cell non-Hodgkin lymphoma

29. Antibody‐Based Therapeutics: Ultrasensitive NIR‐SERRS Probes with Multiplexed Ratiometric Quantification for In Vivo Antibody Leads Validation (Adv. Healthcare Mater. 4/2018)

33. An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation

35. A modifiable universal cotinine-chimeric antigen system of NK cells with multiple targets

36. Heterologous prime-boost regimen elicits potent humoral and cell-mediated immune responses and provides complete protection against SFTSV

43. Spatial epitranscriptomics reveals A-to-I editome specific to cancer stem cell microniches

48. A Novel Anti-CD19 Chimeric Antigen Receptor T Cell Product Targeting a Membrane-Proximal Domain of CD19

49. A Novel Cotinine-Based System for Switchable Chimeric Antigen Receptor T Cell Immunotherapy

Catalog

Books, media, physical & digital resources